ProPhase Labs, Inc. Revenue Breakdown
No Revenue Breakdown for PRPH on this site yet.
- 2025-12-31: Others Not split by product in the filing$4.34M100.00%; Total revenue $4.34M.
- 2024-12-31: Others Not split by product in the filing$6.77M100.00%; Total revenue $6.77M.
- 2023-12-31: Others Not split by product in the filing$34.98M100.00%; Total revenue $34.98M.
- 2022-12-31: Others Not split by product in the filing$122.65M100.00%; Total revenue $122.65M.
Source checked: the stored Revenue Breakdown page for PRPH.
Revenue by product
Each year (12 month)
| Fiscal year end | Others | Total revenue |
|---|---|---|
| 2025-12-31 | Not split by product in the filing $4.34M 100.00% | $4.34M |
| 2024-12-31 | Not split by product in the filing $6.77M 100.00% | $6.77M |
| 2023-12-31 | Not split by product in the filing $34.98M 100.00% | $34.98M |
| 2022-12-31 | Not split by product in the filing $122.65M 100.00% | $122.65M |
| 2021-12-31 | Not split by product in the filing $79.04M 100.00% | $79.04M |
| 2020-12-31 | Not split by product in the filing $14.51M 100.00% | $14.51M |
| 2019-12-31 | Not split by product in the filing $9.88M 100.00% | $9.88M |
| 2018-12-31 | Not split by product in the filing $13.13M 100.00% | $13.13M |
| 2017-12-31 | Not split by product in the filing $9.87M 100.00% | $9.87M |
| 2016-12-31 | Not split by product in the filing $4.21M 100.00% | $4.21M |
| 2015-12-31 | Not split by product in the filing $2.52M 100.00% | $2.52M |
| 2014-12-31 | Not split by product in the filing $22.07M 100.00% | $22.07M |
| 2013-12-31 | Not split by product in the filing $25.03M 100.00% | $25.03M |
| 2012-12-31 | Not split by product in the filing $22.41M 100.00% | $22.41M |
| 2011-12-31 | Not split by product in the filing $17.45M 100.00% | $17.45M |
| 2010-12-31 | Not split by product in the filing $14.50M 100.00% | $14.50M |
| 2009-12-31 | Not split by product in the filing $19.82M 100.00% | $19.82M |
Each quarter (3 month)
| Quarter end | Others | Total revenue |
|---|---|---|
| 2026-06-30 | Not split by product $1.01M 100.00% | $1.01M |
| 2026-03-31 | Not split by product $1.17M 100.00% | $1.17M |
| 2025-12-31 | Not split by product $784.00K 100.00% | $784.00K |
| 2025-09-30 | Not split by product $883.00K 100.00% | $883.00K |
| 2025-06-30 | Not split by product $1.25M 100.00% | $1.25M |
| 2025-03-31 | Not split by product $1.43M 100.00% | $1.43M |
| 2024-12-31 | Not split by product $1.49M 100.00% | $1.49M |
| 2024-09-30 | Not split by product $1.42M 100.00% | $1.42M |
| 2024-06-30 | Not split by product $1.50M 100.00% | $1.50M |
| 2024-03-31 | Not split by product $2.36M 100.00% | $2.36M |
| 2023-12-31 | Not split by product -$5.90M 100.00% | -$5.90M |
| 2023-09-30 | Not split by product $8.37M 100.00% | $8.37M |
| 2023-06-30 | Not split by product $13.22M 100.00% | $13.22M |
| 2023-03-31 | Not split by product $19.30M 100.00% | $19.30M |
| 2022-12-31 | Not split by product $21.82M 100.00% | $21.82M |
| 2022-09-30 | Not split by product $24.20M 100.00% | $24.20M |
| 2022-06-30 | Not split by product $29.09M 100.00% | $29.09M |
| 2022-03-31 | Not split by product $47.53M 100.00% | $47.53M |
| 2021-12-31 | Not split by product $45.16M 100.00% | $45.16M |
| 2021-09-30 | Not split by product $9.47M 100.00% | $9.47M |
| 2021-06-30 | Not split by product $9.14M 100.00% | $9.14M |
| 2021-03-31 | Not split by product $15.27M 100.00% | $15.27M |
| 2020-12-31 | Not split by product $5.16M 100.00% | $5.16M |
| 2020-09-30 | Not split by product $3.84M 100.00% | $3.84M |
| 2020-06-30 | Not split by product $3.62M 100.00% | $3.62M |
| 2020-03-31 | Not split by product $1.89M 100.00% | $1.89M |
| 2019-12-31 | Not split by product $3.14M 100.00% | $3.14M |
| 2019-09-30 | Not split by product $2.77M 100.00% | $2.77M |
| 2019-06-30 | Not split by product $1.65M 100.00% | $1.65M |
| 2019-03-31 | Not split by product $2.32M 100.00% | $2.32M |
| 2018-12-31 | Not split by product $4.09M 100.00% | $4.09M |
| 2018-09-30 | Not split by product $2.44M 100.00% | $2.44M |
| 2018-06-30 | Not split by product $3.19M 100.00% | $3.19M |
| 2018-03-31 | Not split by product $3.41M 100.00% | $3.41M |
| 2017-12-31 | Not split by product $4.15M 100.00% | $4.15M |
| 2017-09-30 | Not split by product $3.04M 100.00% | $3.04M |
| 2017-06-30 | Not split by product $1.91M 100.00% | $1.91M |
| 2017-03-31 | Not split by product $771.00K 100.00% | $771.00K |
| 2016-12-31 | Not split by product $767.00K 100.00% | $767.00K |
| 2016-09-30 | Not split by product $1.40M 100.00% | $1.40M |
| 2016-06-30 | Not split by product $1.02M 100.00% | $1.02M |
| 2016-03-31 | Not split by product $1.02M 100.00% | $1.02M |
| 2015-12-31 | Not split by product $8.16M 100.00% | $8.16M |
| 2015-09-30 | Not split by product $4.39M 100.00% | $4.39M |
| 2015-06-30 | Not split by product $2.19M 100.00% | $2.19M |
| 2015-03-31 | Not split by product $5.86M 100.00% | $5.86M |
| 2014-12-31 | Not split by product $8.97M 100.00% | $8.97M |
| 2014-09-30 | Not split by product $5.13M 100.00% | $5.13M |
| 2014-06-30 | Not split by product $1.80M 100.00% | $1.80M |
| 2014-03-31 | Not split by product $6.17M 100.00% | $6.17M |
| 2013-12-31 | Not split by product $9.60M 100.00% | $9.60M |
| 2013-09-30 | Not split by product $5.95M 100.00% | $5.95M |
| 2013-06-30 | Not split by product $1.94M 100.00% | $1.94M |
| 2013-03-31 | Not split by product $7.54M 100.00% | $7.54M |
| 2012-12-31 | Not split by product $9.08M 100.00% | $9.08M |
| 2012-12-30 | Not split by product $9.08M 100.00% | $9.08M |
| 2012-09-30 | Not split by product $5.42M 100.00% | $5.42M |
| 2012-06-30 | Not split by product $1.89M 100.00% | $1.89M |
| 2012-03-31 | Not split by product $6.02M 100.00% | $6.02M |
| 2011-12-31 | Not split by product $7.46M 100.00% | $7.46M |
| 2011-12-30 | Not split by product $7.46M 100.00% | $7.46M |
| 2011-09-30 | Not split by product $5.08M 100.00% | $5.08M |
| 2011-06-30 | Not split by product $1.74M 100.00% | $1.74M |
| 2011-03-31 | Not split by product $3.17M 100.00% | $3.17M |
| 2010-12-31 | Not split by product $6.19M 100.00% | $6.19M |
| 2010-09-30 | Not split by product $5.20M 100.00% | $5.20M |
| 2010-06-30 | Not split by product $1.13M 100.00% | $1.13M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |